Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)

Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (LCMV)

US Patent 7931893 · Granted Apr 26, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disor2025
Sulfamidase (SGSH) variants, vectors, compositions and methods and uses for trea2025
Method for treating Huntingtons's disease2023
Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disor2023
Compositions and methods for treating fragile X syndrome and related syndromes2022
Compositions and methods for treating Huntington's disease and related disorders2022
CRISPR-related methods and compositions with governing gRNAS2022
Therapeutic for treatment of diseases including the central nervous system2021
Methods of delivery of transgenes for treating brain diseases2021
Compositions and methods of use of CRISPR-Cas systems in nucleotide repeat disor2020
CRISPR-related methods and compositions with governing gRNAs2020
Methods and compositions for treating genetic eye diseases2019